Qiagen N.V. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Qiagen N.V. with three other
pharmaceutical manufacturers in Europe:
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
sales of 365.22 billion Hungarian Forints [US$1.26 billion]
of which 82%
was Pharmaceutical Manufacturing and Sale),
Jazz Pharmaceuticals Plc
(1.20 billion Euro [US$1.28 billion]
of which 100%
was Pharmaceutical Products), and
Krka DD Novo Mesto
based in Slovenia
(1.16 billion Euro [US$1.24 billion]
of which 64%
was European Union).
Qiagen N.V. reported sales of 1.16 billion Euro (US$1.24 billion)
December of 2015.
increase of 14.0%
versus 2014, when the company's sales were 1.02 billion Euro.
Sales at Qiagen N.V. have increased during each of the previous five years
(and since 2010, sales have increased a total of 41%).
Sales of Instrumentation saw an increase
15.8% in 2015, from
130.30 million Euro to 150.87 million Euro.